Search

everythinglearnresearchcommunity

for

Search:↓

Some medications can cause acne, and stopping these drugs is the main treatment.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Finasteride slightly better long-term, minoxidil faster initial results, but stopping minoxidil may cause hair loss.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

New psoriasis treatments are effective but come with side effects and risks.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Hydroxychloroquine may help treat alopecia areata in children.

Effective treatments for severe alopecia areata are still lacking.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Pediatric transplant patients often experience unique skin changes mainly due to medication use.

Older age and prostatic hyperplasia in males increase the risk of hemorrhagic cystitis after stem cell transplantation.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Targeting Keratin 17 may help overcome cancer therapy resistance.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.